Curis Financials
This page shows Curis (CRIS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Curis remains a research-heavy company whose recent loss improvement came from spending cuts, not from a scaled revenue base.
FY2025's much smaller net loss did not make the business self-funding: operating cash burn was still$27.2M while year-end cash was only$5.1M . That mismatch suggests the cleaner earnings picture came mainly from lower expense recognition, while the underlying business still consumed cash faster than its current balance could replenish.
From FY2023 to FY2025, R&D spending fell from
Liquidity tightened sharply as the current ratio dropped from 2.8x in FY2023 to 0.5x in FY2025. With working capital under pressure and financing cash flow still positive in FY2025, the company looked more dependent on outside capital than on internally generated cash.
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Curis's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Curis has an operating margin of -60.5%, meaning the company retains $-61 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -408.3% the prior year.
Curis's revenue declined 13.4% year-over-year, from $10.9M to $9.4M. This contraction results in a growth score of 28/100.
Curis has a moderate D/E ratio of 2.66. This balance of debt and equity financing earns a leverage score of 48/100.
Curis's current ratio of 0.49 is below the typical benchmark, resulting in a score of 4/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Curis generates a -138.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100.
Curis passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Curis generates $3.59 in operating cash flow (-$27.2M OCF vs -$7.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Curis generated $9.4M in revenue in fiscal year 2025. This represents a decrease of 13.4% from the prior year.
Curis's EBITDA was -$5.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 87.5% from the prior year.
Curis reported -$7.6M in net income in fiscal year 2025. This represents an increase of 82.5% from the prior year.
Curis earned $-0.58 per diluted share (EPS) in fiscal year 2025. This represents an increase of 91.6% from the prior year.
Cash & Balance Sheet
Curis held $5.1M in cash against $0 in long-term debt as of fiscal year 2025.
Curis had 13M shares outstanding in fiscal year 2025. This represents an increase of 52.3% from the prior year.
Margins & Returns
Curis's operating margin was -60.5% in fiscal year 2025, reflecting core business profitability. This is up 347.8 percentage points from the prior year.
Curis's net profit margin was -80.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 317.5 percentage points from the prior year.
Curis's ROE was -138.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Capital Allocation
Curis invested $28.3M in research and development in fiscal year 2025. This represents a decrease of 26.7% from the prior year.
CRIS Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0-100.0% | $1.1M-64.2% | $3.2M+15.5% | $2.7M+15.5% | $2.4M-28.8% | $3.3M+14.1% | $2.9M+15.1% | $2.5M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $6.4M+10.7% | $5.8M-9.4% | $6.4M-13.8% | $7.5M-12.7% | $8.5M-4.8% | $9.0M-7.8% | $9.7M-5.2% | $10.3M |
| SG&A Expenses | $5.1M+75.9% | $2.9M-21.1% | $3.7M+3.6% | $3.5M-11.5% | $4.0M+18.8% | $3.4M-10.6% | $3.8M-21.7% | $4.8M |
| Operating Income | -$11.5M-158.7% | $19.6M+383.3% | -$6.9M+16.1% | -$8.3M+18.8% | -$10.2M-12.9% | -$9.0M+14.9% | -$10.6M+15.5% | -$12.5M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$24.2M-225.0% | $19.4M+350.4% | -$7.7M+10.1% | -$8.6M+19.1% | -$10.6M-10.4% | -$9.6M+4.7% | -$10.1M+14.5% | -$11.8M |
| EPS (Diluted) | $-1.25 | N/A | $-0.49+27.9% | $-0.68+45.6% | $-1.25 | N/A | $-1.70+16.3% | $-2.03 |
CRIS Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.7M+48.7% | $20.0M-27.8% | $27.6M-5.4% | $29.2M-25.7% | $39.3M-4.7% | $41.3M-2.8% | $42.5M-15.7% | $50.4M |
| Current Assets | $16.6M+140.2% | $6.9M-50.3% | $13.9M-3.6% | $14.4M-41.9% | $24.8M-6.0% | $26.4M-2.0% | $26.9M-22.0% | $34.5M |
| Cash & Equivalents | $15.0M+196.4% | $5.1M-44.1% | $9.1M-10.7% | $10.1M-50.0% | $20.3M+1.4% | $20.0M-4.1% | $20.9M+108.6% | $10.0M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | $0-100.0% | $3.2M+17.8% | $2.8M+18.9% | $2.3M-30.9% | $3.3M+12.5% | $3.0M+17.0% | $2.5M |
| Goodwill | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M |
| Total Liabilities | $17.0M+17.1% | $14.5M-65.7% | $42.3M-2.1% | $43.2M-5.9% | $45.9M-2.8% | $47.3M-7.7% | $51.2M+0.2% | $51.1M |
| Current Liabilities | $15.0M+6.4% | $14.1M-29.3% | $19.9M+2.8% | $19.4M-3.7% | $20.1M+5.7% | $19.0M-13.6% | $22.0M+13.8% | $19.4M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $12.7M+132.6% | $5.5M+137.2% | -$14.7M-5.0% | -$14.0M-111.7% | -$6.6M-10.2% | -$6.0M+31.3% | -$8.7M-1158.6% | -$694K |
| Retained Earnings | -$1.3B-1.9% | -$1.2B+1.5% | -$1.3B-0.6% | -$1.3B-0.7% | -$1.3B-0.9% | -$1.2B-0.8% | -$1.2B-0.8% | -$1.2B |
CRIS Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$9.0M-41.3% | -$6.4M-14.4% | -$5.6M+30.5% | -$8.0M-10.4% | -$7.3M+21.7% | -$9.3M-56.0% | -$5.9M+46.7% | -$11.1M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $0-100.0% | $2.5M | $0 | $0 | $0+100.0% | -$428K-102.3% | $18.3M+348.9% | -$7.4M |
| Financing Cash Flow | $18.9M+16016.8% | -$119K-102.7% | $4.5M+309.9% | -$2.1M-128.3% | $7.5M-14.7% | $8.8M+679.5% | -$1.5M-4.1% | -$1.5M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CRIS Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -484.0%-2208.0pp | 1724.0%+1942.0pp | -218.0%+82.1pp | -300.1%+126.6pp | -426.8%-157.9pp | -268.9%+91.7pp | -360.5%+130.9pp | -491.4% |
| Net Margin | -1016.8%-2717.6pp | 1700.9%+1944.2pp | -243.4%+69.2pp | -312.6%+133.5pp | -446.0%-158.5pp | -287.5%+56.8pp | -344.3%+119.3pp | -463.6% |
| Return on Equity | -190.4%-544.8pp | 354.4% | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -81.5%-178.5pp | 96.9%+124.9pp | -28.0%+1.4pp | -29.4%-2.4pp | -27.0%-3.7pp | -23.3%+0.5pp | -23.8%-0.4pp | -23.4% |
| Current Ratio | 1.11+0.6 | 0.49-0.2 | 0.70-0.0 | 0.74-0.5 | 1.23-0.2 | 1.39+0.2 | 1.22-0.6 | 1.78 |
| Debt-to-Equity | 1.34-1.3 | 2.66+5.5 | -2.88+0.2 | -3.09+3.9 | -6.95+0.9 | -7.88-2.0 | -5.86+67.8 | -73.64 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.49), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Curis's annual revenue?
Curis (CRIS) reported $9.4M in total revenue for fiscal year 2025. This represents a -13.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Curis's revenue growing?
Curis (CRIS) revenue declined by 13.4% year-over-year, from $10.9M to $9.4M in fiscal year 2025.
Is Curis profitable?
No, Curis (CRIS) reported a net income of -$7.6M in fiscal year 2025, with a net profit margin of -80.3%.
What is Curis's EBITDA?
Curis (CRIS) had EBITDA of -$5.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Curis's operating margin?
Curis (CRIS) had an operating margin of -60.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Curis's net profit margin?
Curis (CRIS) had a net profit margin of -80.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Curis's return on equity (ROE)?
Curis (CRIS) has a return on equity of -138.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Curis's operating cash flow?
Curis (CRIS) generated -$27.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Curis's total assets?
Curis (CRIS) had $20.0M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Curis spend on research and development?
Curis (CRIS) invested $28.3M in research and development during fiscal year 2025.
What is Curis's current ratio?
Curis (CRIS) had a current ratio of 0.49 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Curis's debt-to-equity ratio?
Curis (CRIS) had a debt-to-equity ratio of 2.66 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Curis's return on assets (ROA)?
Curis (CRIS) had a return on assets of -38.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Curis's cash runway?
Based on fiscal year 2025 data, Curis (CRIS) had $5.1M in cash against an annual operating cash burn of $27.2M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Curis's Piotroski F-Score?
Curis (CRIS) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Curis's earnings high quality?
Curis (CRIS) has an earnings quality ratio of 3.59x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Curis?
Curis (CRIS) scores 13 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.